May 03, 2012 at 07:30 AM EDT
Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference

SYDNEY, AUSTRALIA -- (Marketwire) -- 05/03/12 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) announced today that Dr. Neil Frazer, Chief Medical Officer, will present at the Deutsche Health Care Conference on Tuesday, May 8, 2012 at 8:40am Eastern Time in Boston, MA. Dr. Frazer will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Prima BioMed's website at http://www.primabiomed.com.au/investor/presentations.php. A replay of the webcast will be available for 10 business days following the presentation.

About Prima BioMed
Prima BioMed is a NASDAQ and ASX and listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.

Prima's lead product is the CVac™ ovarian cancer therapy treatment. CVac™ has completed two successful clinical trials and is progressing advanced clinical development in the United States, Australia, and Europe.

The Company's broader, long term goal is to develop cancer treatment technologies and programs for global markets.

Contacts:
Dr. Neil Frazer
Chief Medical Officer
Prima BioMed
Ph: (919) 654 6736
E: Email Contact

US Investor Relations
Ms. Kathy Galante
Investor Relations
Burns McClellan, Inc
Ph: (212) 213-0006
E: Email Contact

Australia Investor / Media
James Moses
Investor and Media Relations
Mandate Corporate
Ph: +61 0 420 991 574
E: Email Contact

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here